Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples